BTIG Starts Biodesix (BDSX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Canaccord Genuity Starts Biodesix (BDSX) at Buy
November 23, 2020 7:50 AM ESTCanaccord Genuity analyst Max Masucci initiates coverage on Biodesix (NASDAQ: BDSX) with a Buy rating and a price target of $26.00.
For an analyst ratings summary and ratings history on Biodesix click here. For more ratings news on Biodesix click here.
Shares of Biodesix closed at $17.50 yesterday.
... More